Sign in
4

Changes in Ownership

HERON THERAPEUTICS, INC. /DE/ Filed Acc 0000818033-09-000002

Options or other derivatives

  • Vice President of R&D acquired 160,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

BARR JOHN · Vice President of R&D

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2009-01-16 Grant or award : show line 1 in the form Non-Qualified Stock Option (right to buy) +160,000 $0.71 2019-01-16 160,000 160,000 D
Loading xslF345X03/edgardoc.xml…